|
[1]Chinese Expert Consensus Statement Chinese Society of Liver Cancer(CSLC),Chinese Society of Clinical Oncology(CSCO),Liver Cancer Group,Chinese Society of Hepatology,et al.Experts consensus on pathological diagnosis of primary liver cancer[J].J Clin Hepatol,2011,27(4):343-345.(in Chinese)中国抗癌协会肝癌专业委员会,中国抗癌协会临床肿瘤学协作专业委员会,中华医学会肝病学分会肝癌学组,等.原发性肝癌规范化病理诊断方案专家共识[J].临床肝胆病杂志,2011,27(4):343-345.
|
|
[2]KOH C,ZHAO X,SAMALA N,et al.AASLD clinical practice guidelines:a critical review of scientific evidence and evolving recommendations[J].Hepatology,2013,58(6):2142-2152.
|
|
[3]WILLIAM H,RALPH H,TIMOTHY H,et al.Surgical pathology dissection:an illustrated guide[M].New York:Springer,2003:7-9.
|
|
[4] Chinese Medical Association.Clinical operation norm:pathology[M].Beijing:People's Military Medical Press,2004:27-41.(in Chinese)中华医学会.临床技术操作规范·病理学分册[M].北京:人民军医出版社,2004:27-41.
|
|
[5]BASS BP,ENGEL KB,GREYTAK SR,et al.A review of preanalytical factors affecting molecular,protein,and morphological analysis of formalin-fixed,paraffin-embedded(FFPE)tissue:how well do you know your FFPE specimen?[J].Arch Pathol Lab Med,2014,138(11):1520-1530.
|
|
[6]LU XY,XI T,LAU WY,et al.Hepatocellular carcinoma expressing cholangiocyte phenotype is a novel subtype with highly aggressive behavior[J].Ann Surg Oncol,2011,18(8):2210-2217.
|
|
[7]CAI SW,YANG SZ,GAO J,et al.Prognostic significance of mast cell count following curative resection for pancreatic ductal adenocarcinoma[J].Surgery,2011,149(4):576-584.
|
|
[8] YING YH.Pathology of hepatocellular carcinoma[M]//TANG ZY.Primary liver cancer.Shanghai:Shanghai Science and Technology Press,1981:115-146.(in Chinese)应越英.肝细胞肝癌的病理学[M]//汤钊猷.原发性肝癌.上海:上海科学技术出版社,1981:115-146.
|
|
[9]Ministry of Health of the People's Republic of China.Diagnosis,management,and treatment of hepatocellular carcinoma(V2011)[J].J Clin Hepatol,2011,27(11):1141-1159.(in Chinese)中华人民共和国卫生部.原发性肝癌诊疗规范(2011年版)[J].临床肝胆病杂志,2011,27(11):1141-1159.
|
|
[10]NAKANUMA Y,CURADO MP,FRANCESCHI S,et al.Intrahepatic cholangiocarcinoma[M]//BOSMAN FT,CARNEIRO F,HRUBAN RH,et al.WHO classification of tumours of the digestive system.4th Ed.Lyon:IARC Press,2010:217-227.
|
|
[11]CONG WM,WU MC.Small hepatocellular carcinoma:current and future approaches[J].Hepatol Int,2013,7(3):805-812.
|
|
[12]LU XY,XI T,LAU WY,et al.Pathobiological features of small hepatocellular carcinoma:correlation between tumor size and biological behavior[J].J Cancer Res Clin Oncol,2011,137(4):567-575.
|
|
[13]MORIBE T,IIZUKA N,MIURA T,et al.Methylation of multiple genes as molecular markers for diagnosis of a small,well-differentiated hepatocellular carcinoma[J].Int J Cancer,2009,125(2):388-397.
|
|
[14]LLOVET JM,CHEN Y,WURMBACH E,et al.A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis[J].Gastroenterology,2006,131(6):1758-1767.
|
|
[15]UENO S,KUBO F,SAKODA M,et al.Efficacy of anatomic resection vs nonanatomic resection for small nodular hepatocellular carcinoma based on gross classification[J].J Hepatobiliary Pancreat Surg,2008,15(5):493-500.
|
|
[16]FARINATI F,SERGIO A,BALDAN A,et al.Early and very early hepatocellular carcinoma:when and how much do staging and choice of treatment really matter?A multi-center study[J].BMC Cancer,2009,9:33.
|
|
[17]WU MC.Strengthening to diagnosis and treatment of hepatocellular carcinoma[J].Natl Med J China,2007,87(30):2089-2091.(in Chinese)吴孟超.应重视小肝癌的诊断与治疗[J].中华医学杂志,2007,87(30):2089-2091.
|
|
[18]THEISE ND,CURADO MP,FRANCESCHI S,et al.Hepatocellular carcinoma[M]//BOSMAN FT,CARNEIRO F,HRUBAN RH,et al.WHO classification of tumours of the digestive system.4th Ed.Lyon:IARC Press,2010:205-216.
|
|
[19]HU XQ.Histopathological staging and assessment of liver fibrosis in chronic hepatitis patients[J].Chin J Hepatol,2008,16(3):169-170.(in Chinese)胡锡琪.慢性肝炎肝纤维化病理分期和评估[J].中华肝脏病杂志,2008,16(3):169-170.
|
|
[20]DESMET VJ,GERBER M,HOOFNAGLE JH,et al.Classification of chronic hepatitis:diagnosis,grading and staging[J].Hepatology,1994,19(6):1513-1520.
|
|
[21]KNODELL RG,ISHAK KG,BLACK WC,et al.Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis[J].Hepatology,1981,1(5):431-435.
|
|
[22]SCHEUER PJ.Classification of chronic viral hepatitis:a need for reassessment[J].J Hepatol,1991,13(3):372-374.
|
|
[23]BATTS KP,LUDWIG J.Chronic hepatitis.An update on terminology and reporting[J].Am J Surg Pathol,1995,19(12):1409-1417.
|
|
[24]BEDOSSA P,POYNARD T.An algorithm for the grading of activity in chronic hepatitis C.The METAVIR Cooperative Study Group[J].Hepatology,1996,24(2):289-293.
|
|
[25]ISHAK K,BAPTISTA A,BIANCHI L,et al.Histological grading and staging of chronic hepatitis[J].J Hepatol,1995,22(6):696-699.
|
|
[26]Chinese Society of Infectious Diseases and Parasitology,Chinese Society of Hepatology,Chinese Medical Association.Prevention and treatment of viral hepatitis[J].Chin J Hepatol,2000,8(6):324-329.(in Chinese)中华医学会传染病与寄生虫病学分会,肝病学分会.病毒性肝炎防治方案[J].中华肝脏病杂志,2000,8(6):324-329.
|
|
[27]International Consensus Group for Hepatocellular Neoplasia.Pathologic diagnosis of early hepatocellular carcinoma:a report of the international consensus group for hepatocellular neoplasia[J].Hepatology,2009,49(2):658-664.
|
|
[28]DI TOMMASO L,SANGIOVANNI A,BORZIO M,et al.Advanced precancerous lesions in the liver[J].Best Pract Res Clin Gastroenterol,2013,27(2):269-284.
|
|
[29]TOYOSAKA A,OKAMOTO E,MITSUNOBU M,et al.Pathologic and radiographic studies of intrahepatic metastasis in hepatocellular carcinoma;the role of efferent vessels[J].HPB Surg,1996,10(2):97-103.
|
|
[30]TOYOSAKA A,OKAMOTO E,MITSUNOBU M,et al.Intrahepatic metastases in hepatocellular carcinoma:evidence for spread via the portal vein as an efferent vessel[J].Am J Gastroenterol,1996,91(8):1610-1615.
|
|
[31]RODRIGUEZ-PERALVAREZ M,LUONG TV,ANDREANA L,et al.A systematic review of microvascular invasion in hepatocellular carcinoma:diagnostic and prognostic variability[J].Ann Surg Oncol,2013,20(1):325-339.
|
|
[32]EGUCHI S,TAKATSUKI M,HIDAKA M,et al.Predictor for histological microvascular invasion of hepatocellular carcinoma:a lesson from 229 consecutive cases of curative liver resection[J].World J Surg,2010,34(5):1034-1038.
|
|
[33]IGUCHI T,SHIRABE K,AISHIMA S,et al.New pathologic stratification of microvascular invasion in hepatocellular carcinoma:predicting prognosis after living-donor liver transplantation[J].Transplantation,2014.[Epub ahead of print]
|
|
[34]DU M,CHEN L,ZHAO J,et al.Microvascular invasion(MVI)is a poorer prognostic predictor for small hepatocellular carcinoma[J].BMC Cancer,2014,14(1):38.
|
|
[35]ROAYAIE S,BLUME IN,THUNG SN,et al.A system of classifying microvascular invasion to predict outcome after resection in patients with hepatocellular carcinoma[J].Gastroenterology,2009,137(3):850-855.
|
|
[36]SUMIE S,NAKASHIMA O,OKUDA K,et al.The significance of classifying microvascular invasion in patients with hepatocellular carcinoma[J].Ann Surg Oncol,2014,21(3):1002-1009.
|
|
[37]PAWLIK TM,DELMAN KA,VAUTHEY JN,et al.Tumor size predicts vascular invasion and histologic grade:implications for selection of surgical treatment for hepatocellular carcinoma[J].Liver Transpl,2005,11(9):1086-1092.
|
|
[38]OKUSAKA T,OKADA S,UENO H,et al.Satellite lesions in patients with small hepatocellular carcinoma with reference to clinicopathologic features[J].Cancer,2002,95(9):1931-1937.
|
|
[39]LIM C,MISE Y,SAKAMOTO Y,et al.Above 5 cm,size does not matter anymore in patients with hepatocellular carcinoma[J].World J Surg,2014,38(11):2910-2918.
|
|
[40]SHI M,ZHANG CQ,FENG KT,et al.Micrometastasis distribution in liver tissue surrounding hepatocellular carcinoma[J].Chin J Oncol,2002,4(3):257-260.(in Chinese)石明,张昌卿,冯凯涛,等.肝细胞癌周围微小转移分布的研究[J].中华肿瘤杂志,2002,4(3):257-260.
|
|
[41]CHICHE L,MENAHEM B,BAZILLE C,et al.Recurrence of hepatocellular carcinoma in noncirrhotic liver after hepatectomy[J].World J Surg,2013,37(10):2410-2418.
|
|
[42]MENICONI RL,KOMATSU S,PERDIGAO F,et al.Recurrent hepatocellular carcinoma:a western strategy that emphasizes the impact of pathologic profile of the first resection[J].Surgery,2015,157(3):454-462.
|
|
[43]ROCKEY DC,CALDWELL SH,GOODMAN ZD,et al.Liver biopsy[J].Hepatology,2009,49(3):1017-1044.
|
|
[44]CONG WM,DONG H,XIAN ZH.Tumors of the liver and intrahepatic bile duct system[M]//.WU BQ,LIU YF.Immunohistochemical pathologic diagnosis.2nd.Beijing:Beijing Science and Technology Press,2013:334-345.(in Chinese)丛文铭,董辉,冼志红.肝脏和肝内胆管系统肿瘤[M]//.吴秉铨,刘彦仿.免疫组织化学病理诊断.2版.北京:北京科学技术出版社,2013:334-345.
|
|
[45]ORDONEZ NG.Arginase-1 is a novel immunohistochemical marker of hepatocellular differentiation[J].Adv Anat Pathol,2014,21(4):285-290.
|
|
[46]GOVAERE O,KOMUTA M,BERKERS J,et al.Keratin 19:a key role player in the invasion of human hepatocellular carcinomas[J].Gut,2014,63(4):674-685.
|
|
[47]XIA L,HUANG W,TIAN D,et al.Upregulated Fox M1 expression induced by hepatitis B virus X protein promotes tumor metastasis and indicates poor prognosis in hepatitis B virus-related hepatocellular carcinoma[J].J Hepatol,2012,57(3):600-612.
|
|
[48]ROESSLER S,BUDHU A,WANG XW.Deciphering cancer heterogeneity:the biological space[J].Front Cell Dev Biol,2014,2:12.
|
|
[49]YANG X,ZHANG XF,LU X,et al.MicroRNA-26a suppresses angiogenesis in human hepatocellular carcinoma by targeting hepatocyte growth factor-c Met pathway[J].Hepatology,2014,59(5):1874-1885.
|
|
[50]WANG B,XIA CY,LAU WY,et al.Determination of clonal origin of recurrent hepatocellular carcinoma for personalized therapy and outcomes evaluation:a new strategy for hepatic surgery[J].J Am Coll Surg,2013,217(6):1054-1062.
|
|
[51]ZHU YY,GU YJ,LU XY,et al.The clonal characteristics of late recurrent hepatocellular carcinoma after resection:a study of 2 cases[J].Chin J Oncol,2014,36(6):450-452.(in Chinese)朱玉瑶,顾怡瑾,陆新元,等.二例术后远期复发性肝细胞癌的克隆特点分析[J].中华肿瘤杂志,2014,36(6):450-452.
|
|
[52]MATSUMOTO Y,FUJII H,MATSUDA M,et al.Multicentric occurrence of hepatocellular carcinoma:diagnosis and clinical significance[J].J Hepatobiliary Pancreat Surg,2001,8(5):435-440.
|
|
[53]FINKELSTEIN SD,MARSH W,DEMETRIS AJ,et al.Microdissection-based allelotyping discriminates de novo tumor from intrahepatic spread in hepatocellular carcinoma[J].Hepatology,2003,37(4):871-879.
|
|
[54]GEHRAU R,MAS V,ARCHER KJ,et al.Molecular classification and clonal differentiation of hepatocellular carcinoma:the step forward for patient selection for liver transplantation[J].Expert Rev Gastroenterol Hepatol,2011,5(4):539-552.
|
|
[55]LIAU SS,QURESHI MS,PRASEEDOM R,et al.Molecular pathogenesis of hepatic adenomas and its implications for surgical management[J].J Gastrointest Surg,2013,17(10):1869-1882.
|
|
[56]CONG WM,WU MC.New ideas for molecular pathological diagnosis of liver cancer and new strategy for clinical treatment[J].Natl Med J China,2014,94(20):1521-1523.(in Chinese)丛文铭,吴孟超.肝癌分子病理诊断新思路与临床治疗新策略[J].中华医学杂志,2014,94(20):1521-1523.
|
|
[57]WASHINGTON MK,BERLIN J,BRANTON PA,et al.Protocol for the examination of specimens from patients with carcinoma of the intrahepatic bile ducts[J].Arch Pathol Lab Med,2010,134(4):e14-e18.
|
DownLoad: